1-3 of 3
Keywords: Tyrosine kinase inhibitors
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (2008) 216 (3): 247–249.
Published Online: 09 January 2008
...J. Lübbe; I. Masouyé; P.-Y. Dietrich Erlotinib is a small molecule tyrosine kinase inhibitor that is used as an anticancer agent. Most patients develop a pustular facial dermatitis within the first week of treatment. Pyogenic granulomas of the nail folds are another typical adverse event occurring...